These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3109094)

  • 1. Electron microscopic investigations of the cyclophosphamide-induced lesions of the urinary bladder of the rat and their prevention by mesna.
    Themann H; Oberdorf E; Brock N; Pohl J
    Urol Int; 1987; 42(1):37-43. PubMed ID: 3109094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of cyclophosphamide cystitis with 2-mercaptoethane sodium sulfonate: a histologic study.
    Freedman A; Ehrlich RM; Ljung BM
    J Urol; 1984 Sep; 132(3):580-2. PubMed ID: 6433044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of mesna in preventing further cyclophosphamide-induced hemorrhagic cystitis.
    Luce JK; Simons JA
    Med Pediatr Oncol; 1988; 16(6):372-4. PubMed ID: 3143903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the uroprotector sodium 2-mercaptoethane sulfonate (Mesna) on the proliferation of the bladder urothelium in the rat after administration of cyclophosphamide.
    Kunze E; Köhnecke B; Engelhardt W; Steinröder H; Brock N; Pohl J
    Urol Int; 1984; 39(2):61-7. PubMed ID: 6426112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prevention of tumor formation in the bladder by sodium-2-mercaptoethane sulfonate (mesna). Experimental studies and clinical consequences].
    Schmähl D; Habs M; Tacchi AM
    Urologe A; 1984 Sep; 23(5):291-6. PubMed ID: 6438859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesna versus forced diuresis to prevent cyclophosphamide induced haemorrhagic cystitis in marrow transplant patients (preliminary data).
    Hows J; Mehta A; Gordon-Smith EC
    Cancer Treat Rev; 1983 Sep; 10 Suppl A():53-6. PubMed ID: 6414696
    [No Abstract]   [Full Text] [Related]  

  • 7. [Autoradiographic studies on the protective effect of mesna in the urinary bladder mucosa of the rat during administration of cyclophosphamide (preliminary communication)].
    Kunze E; Köhnecke B; Engelhardt W; Brock N; Pohl J
    Arzneimittelforschung; 1983; 33(6):853-4. PubMed ID: 6412725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclophosphamide-induced Down-Regulation of Uroplakin II in the Mouse Urinary Bladder Epithelium is Prevented by S-Allyl Cysteine.
    Abdi SA; Najmi AK; Raisuddin S
    Basic Clin Pharmacol Toxicol; 2016 Dec; 119(6):598-603. PubMed ID: 27234646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prevention of urotoxic complications during therapy with cytostatics. The problem of the interaction between sodium-II-mercaptoethanesulfonate and cyclophosphamide].
    Possinger K; Ehrhart H; Misera C; Hartenstein R
    Fortschr Med; 1981 Oct; 99(40):1650-2. PubMed ID: 6795099
    [No Abstract]   [Full Text] [Related]  

  • 10. Prophylaxis of haemorrhagic cystitis due to cyclophosphamide-conditioning for bone marrow transplantation.
    Link H; Neef V; Niethammer D; Wilms K
    Blut; 1981 Nov; 43(5):329-30. PubMed ID: 6799018
    [No Abstract]   [Full Text] [Related]  

  • 11. Prevention of urinary bladder tumors in cyclophosphamide-treated rats by additional medication with the uroprotectors sodium 2-mercaptoethane sulfonate (mesna) and disodium 2,2'-dithio-bis-ethane sulfonate (dimesna).
    Habs MR; Schmähl D
    Cancer; 1983 Feb; 51(4):606-9. PubMed ID: 6401591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Architectural ultrastructure of the urinary bladder epithelium. II. Changes in the urine-blood barrier in the contracted and distended state in the normal and inflammatory bladder].
    Konishi T
    Hinyokika Kiyo; 1988 Jan; 34(1):23-31. PubMed ID: 3376802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The development of mesna for regional detoxification.
    Brock N; Pohl J
    Cancer Treat Rev; 1983 Sep; 10 Suppl A():33-43. PubMed ID: 6414694
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of mesna with forced diuresis to prevent cyclophosphamide induced haemorrhagic cystitis in marrow transplantation: a prospective randomised study.
    Hows JM; Mehta A; Ward L; Woods K; Perez R; Gordon MY; Gordon-Smith EC
    Br J Cancer; 1984 Dec; 50(6):753-6. PubMed ID: 6437430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The development of mesna for the inhibition of urotoxic side effects of cyclophosphamide, ifosfamide, and other oxazaphosphorine cytostatics.
    Brock N
    Recent Results Cancer Res; 1980; 74():270-8. PubMed ID: 6777836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protecting the bladder from cyclophosphamide with mesna.
    Finn GP; Sidau B; Shaw IC
    N Engl J Med; 1986 Jan; 314(1):61. PubMed ID: 3079620
    [No Abstract]   [Full Text] [Related]  

  • 17. Prevention of cyclophosphamide-induced carcinogenesis in the urinary bladder of rats by administration of mesna.
    Schmähl D; Habs MR
    Cancer Treat Rev; 1983 Sep; 10 Suppl A():57-61. PubMed ID: 6414697
    [No Abstract]   [Full Text] [Related]  

  • 18. Contribution of flavonoid antioxidants to the preventive effect of mesna in cyclophosphamide-induced cystitis in rats.
    Ozcan A; Korkmaz A; Oter S; Coskun O
    Arch Toxicol; 2005 Aug; 79(8):461-5. PubMed ID: 15800758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of sodium 2-mercaptoethane sulfonate to prevent cyclophosphamide cystitis.
    Ehrlich RM; Freedman A; Goldsobel AB; Stiehm ER
    J Urol; 1984 May; 131(5):960-2. PubMed ID: 6423841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesna and oxazaphosphorine cancer chemotherapy.
    Shaw IC
    Cancer Treat Rev; 1987 Dec; 14(3-4):359-64. PubMed ID: 3125971
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.